Hypermarcas (OTCMKTS:HYPMY) Shares Pass Below 50-Day Moving Average - What's Next?

Key Points

• Hypermarcas shares fell below their 50-day moving average of $4.46, trading as low as $4.30 during recent market activity.
• Analysts have given Hypermarcas a strong-buy rating, indicating positive sentiment towards the company's stock performance.
• The company announced a dividend of $0.0345 per share, which is set to yield 281.0% for shareholders of record by the ex-dividend date.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $4.46 and traded as low as $4.30. Hypermarcas shares last traded at $4.64, with a volume of 2,195 shares changing hands.

Wall Street Analyst Weigh In

Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a research report on Thursday, July 17th. One analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Strong Buy".

Hypermarcas Stock Performance

The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80. The company has a 50 day simple moving average of $4.46 and a 200-day simple moving average of $4.17. The stock has a market cap of $2.94 billion, a P/E ratio of 22.10 and a beta of 0.86.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $0.12 earnings per share for the quarter. Hypermarcas had a return on equity of 6.19% and a net margin of 11.28%.

Hypermarcas Dividend Announcement

The company also recently announced a dividend, which will be paid on Friday, January 8th. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.0345 per share. The ex-dividend date is Monday, June 30th. This represents a dividend yield of 281.0%. Hypermarcas's dividend payout ratio is 57.14%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.